factor XIIa inhibitors (LUNAC Therapeutics)

N/A

Report date: 2025/03/20 16:11:14
NME

Base Information

Drug Namefactor XIIa inhibitors (LUNAC Therapeutics)
Drug Alias Namefactor XIIa inhibitors (University of Leeds)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor XIIa antagonists
TargetsCoagulation factor XII
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Leeds
China Registration ClassN/A

Develop Information

Active CompaniesLUNAC Therapeutics
Inactive CompaniesUniversity Of Leeds
Active IndicationsThrombosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A